alexa Locally Advanced Anaplastic Thyroid Carcinoma with Long-Term Survival of More Than 7 Years after Combined Surgery Including Tracheal Resection and Radiotherapy: Case Report
ISSN: 2161-119X
Otolaryngology: Open Access

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
  • Case Report   
  • Otolaryngol (Sunnyvale) 2015, Vol 5(4): 197
  • DOI: 10.4172/2161-119X.1000197

Locally Advanced Anaplastic Thyroid Carcinoma with Long-Term Survival of More Than 7 Years after Combined Surgery Including Tracheal Resection and Radiotherapy: Case Report

Wei Zhong Ernest Fu1*, Ming Yann Lim1, Khoon Leong Chuah2, Khoon Leong Chuah1 and Li-Chung Mark Khoo1
1Department of Otolaryngology, Tan Tock Seng Hospital, Singapore
2Department of Pathology, Tan Tock Seng Hospital, Singapore
*Corresponding Author: Wei Zhong Ernest Fu, Department of Otolaryngology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, Tel: 65-97103536, Email: [email protected]

Received Date: May 15, 2014 / Accepted Date: Jun 11, 2015 / Published Date: Jun 16, 2015

Abstract

We present a case of locally advanced Anaplastic Thyroid Carcinoma (ATC) with tracheal invasion in a 67-yearold elderly Chinese man who was treated with radical surgery encompassing total thyroidectomy, neck dissection and tracheal resection followed by adjuvant radiotherapy. Long-term disease-free survival is more than 7 years to date. A 10-year literature review of locally advanced ATC with long-term survival (more than 2 years) is also presented.

Keywords: Anaplastic thyroid carcinoma, Long term survival, Tracheal invasion

Introduction

Anaplastic thyroid carcinoma (ATC) accounts for about 2% of all thyroid carcinomas and is one of the most aggressive human malignancies [1-4]. In most series, mean survival time from diagnosis is 6 months regardless of treatment [5-13]. Peak incidence is usually more than 60 years of age and it occurs more commonly in females than males. Patients usually present with symptoms of extensive local invasion such as pain, dysphagia, hoarseness, respiratory distress and a rapidly enlarging neck mass.

We present a case of locally advanced ATC with trachea invasion in an elderly male that was treated with radical surgery and adjuvant radiotherapy with long-term disease-free survival of more than 7 years.

Case Report

A 67-year-old Chinese man first presented to us with a left neck mass of 2 months’ duration associated with hoarseness and compressive symptoms of 1 month.

He was a previous smoker and had a history of bilateral pulmonary silicosis, having previously worked in a granite quarry for more than 25 years. He has no family history of thyroid disease or previous exposure to irradiation.

On examination, there was a hard 4 cm left thyroid mass that was fixed to the larynx and trachea. There were no palpable cervical nodes. Nasoendoscopy examination revealed left vocal cord paresis in the adducted position. Computed tomography (CT) revealed a left thyroid lesion with possible tracheal invasion (Figure 1). The left vocal fold was abducted. There was no evidence of metastatic cervical lymphadenopathy and systemic review was negative for distant metastasis. Fine-needle aspiration cytology (FNAC) showed features of a high-grade malignant tumour with necrosis favouring an anaplastic carcinoma of the thyroid. Thyroid function tests were normal.

He underwent elective total thyroidectomy, bilateral level 6 neck dissection, and tracheal resection with primary end-to-end anastomosis. There was frank tracheal invasion with gross tumour seen intra-luminally. Frozen section analysis showed a malignant highgrade neoplasm. Surgery was otherwise uneventful and he recovered well post-operatively with no complications. He was discharged well 12 days after surgery.

Final histology showed anaplastic carcinoma of the isthmus and left hemithyroid measuring 5 × 3.7 × 2.5 cm. It was a high-grade neoplasm composed of epithelioid and spindle cells with marked anisonucleosis. Necrosis and mitotic activity including tripolar mitotic figures were present (Figure 2). The tumour had infiltrated posteriorly into the adjacent trachea reaching the connective tissue below the epithelial lining of the trachea and was 2 mm from the closest tracheal margin. No follicular or papillary component was noted despite extensive sampling. On immunohistochemistry, the tumour was positive for cytokeratin AE1/3 but not CD31. A total of 11 level 6 lymph nodes were negative for tumour.

He subsequently underwent adjuvant intensity-modulated radiation therapy (IMRT) of 66Gy over 33 fractions. He has since been on regular follow-up and to date has been disease-free for more than 7 years. Post-treatment CT scans has showed no evidence of local recurrence or distant metastasis. He is on thyroxine replacement.

otolaryngology-Hypodense-left

Figure 1: Hypodense left thyroid lesion 4.0 × 3.9 cm causing displacement of the trachea to the right with invasion of left lateral wall of the trachea with a polypoidal enhancing mass of tissue seen protruding into the tracheal lumen.

otolaryngology-mitotic-figure

Figure 2: High-powered view of thyroid neoplasm disclosing a proliferation of epithelioid and spindle cells with nuclear pleomorphism amidst a fibrotic background. Note the presence of a tripolar mitotic figure (arrow). (Haematoxylin and eosin stain).

Discussion

ATC is one of the most lethal human cancers and to date, the management remains challenging and controversial. Based on the American Thyroid Guidelines on ATC published in 2012 [14], in patients with extra-thyroidal invasion, an en bloc resection should be considered if grossly negative margins (R1 resection) could be achieved.

There have been many studies looking at various prognostic factors affecting survival. Kebebew et al. [5] studied a cohort of 516 patients with ATC wherein multivariate analysis showed that although most patients with ATC had an extremely poor prognosis, patients less than 60 years old with intra-thyroidal tumours survived longer. Surgical resection with external beam radiotherapy was associated with lower cause-specific mortality.

Other studies have variably shown that younger age, tumour size less than 6 cm, localized disease, female gender, and tumour resectability are independent predictors of lower cause-specific mortality [8,15-17]. In particular, complete surgical resection appears to be an important determinant of survival. Haigh et al. [18] reported that the primary factor associated with survival was potential curative surgery. In their study, neither tumour size nor age influenced survival. Kobayashi et al. [19] also observed that complete tumour resection achieved better prognosis and that age did not significantly impact survival.

In contrast to the above findings, Sugitani et al. [9] performed a retrospective analysis of 44 patients with ATC and devised a novel prognostic index (PI) based on four prognostic factors to select patients for aggressive multimodal treatment. The features were the presence of acute symptoms, large tumour size (>5 cm), distant metastasis, and leukocytosis (white blood cell count >10,000/mm3), but notably did not include complete surgical resection. The presence of acute symptoms and large tumour size probably reflect rapid disease progression. Smaller tumour size may correlate with resectability. Patients with distant metastasis inevitably do poorly and the presence of leukocytosis likely represent the late stage of specific subtypes of ATC secreting granulocyte colony-stimulating factor (G-CSF) or related cytokines. The PI is calculated by totaling the number of unfavourable prognostic factors a given patient possessed: 0 to 4. The study showed that patients whose PI was ≤ 1 had a 62% survival rate at 6 months. No patients whose PI was ≥ 3 survived more than 6 months and all patients whose PI was 4 died within 3 months. The authors also noted that the mean PI of the patients treated by multimodal therapy was 0.6 (either 0 or 1), whereas the PI of those who were not was 2.3, and hence proposed that multimodal treatment be advocated for PI of ≤1 while aggressive treatment is avoided when PI is ≥ 3.

Orita et al. [20] recently published the prospective application of this PI in the treatment strategy of 74 patients with ATC. 6-month survival rates for PI ≤ 1 and PI ≥ 3 were 72% and 12%, respectively. Both groups (P1 ≤ 1 and ≥ 3) demonstrated significantly better diseasespecific survival as compared to the previous study above. Within each group, the survival rates did not differ between stages. The authors thus concluded that the PI is valid for anticipating prognosis and aiding timely decisions on treatment policy for ATC.

For our patient, long-term survival with no evidence of disease after 7 years is unusual, especially considering the presence of tracheal invasion. However, based on the above PI, he has a PI of 1 for tumour size, which indicated that he would have benefitted from the multimodal treatment he received.

In the past, there has been anecdotal evidence of cases of ATC with long-term survival. Since the mid-1980s, a group of poorly differentiated thyroid cancers (PDTC) has been recognized and considered to be tumours of biological aggressiveness intermediate between the more indolent well-differentiated thyroid carcinomas and ATC [21]. Historically, the distinction between poorly differentiated thyroid cancer (PDTC) and ATC has always been difficult. In our patient, there was no question that the tumour was an ATC.

We carried out a literature review of all ATC cases with survival greater than 2 years. Prior to review, we identified several features thought to influence survival as discussed above, namely age, tumour size, extent of tumour spread, adequacy of surgical resection, histopathology and neoadjuvant/adjuvant therapy. We restricted our review to papers published after January 1990. Exclusion criteria included papers not published in peer-reviewed journals as well as any case series in which the prognostic factors for the longest surviving cases were not specified. Medical subject headings and main keywords used were: ‘undifferentiated’, ‘anaplastic’ and ‘thyroid’, with variants of the main keywords also applied.

The initial review yielded a total of 37 articles, 10 case reports and 21 case series. 13 case series were further excluded due to insufficient data. We further excluded 3 case reports and 1 case series with only intra-thyroidal ATC tumours (T4a) for ease of comparison. A total of 7 case reports and 7 case series remained for our review.

A total of 22 cases of locally advanced ATC (T4b) with long-term survival of more than 2 years were compiled from the remaining 14 articles (Table 1). The length of survival varied from more than 2 to 12 years. The age at diagnosis ranged from 26 to 85 years. 4 cases [22- 24] were diagnosed with ATC incidentally after surgery for presumed benign thyroid disease. Of cases that were known, most did not present with acute symptoms, usually that of a rapidly enlarging neck mass. Only 3 cases [22,25,26] had evidence of tracheal invasion while 1 case [27] had tumour extending to the cervical esophagus.

All cases received multi-modality treatment with most cases being treated with radical surgery followed by either concurrent chemoradiation or radiotherapy or radioactive iodine ablation. Only 3 cases [27-29] received neoadjuvant chemoradiation followed by surgery. The extent of thyroidectomy performed also differed and ranged from lobectomy to total thyroidectomy. All patients with clinically or radiologically positive cervical lymph nodes underwent neck dissections. Surgical resection included debulking surgery, macroscopically complete resections and microscopically complete resections. In general, most studies concluded that although the prognosis of most patients with ATC continues to be poor, complete resection combined with adjuvant chemotherapy and radiotherapy resulted in better survival.

SN Journal Age/
Gender
Presentation Extent of surgery Positive margins Neoadjuvant / Adjuvant Therapy Tumour size (cm) Formal Histopathology Presence of extrathyroidal spread & location TMN Stage Length of survival
1 Kanaseki et al.[25] 52/F Enlarging anterior neck mass with vocal cord palsy TT with tracheal wall resection
Interval upper mediastinal LN dissection
No Adjuvant CTX followed by CRT 9.0 × 6.5 × 3.0 ATC with tracheal invasion Positive superior mediastinal LN Yes Tracheal wall and mediastinal LN Stage IVB
T4bN1bM0
>2 years
2 Shinohara et al. [27] 53/F Anterior neck pain with left thyroid nodule Total pharyngo–laryngo–esophagectomy with bilateral neck and upper mediastinum LN dissection No Neoadjuvant CTX followed by RT Tumour regrowth on MRI after RT, proceeded with surgery 4.1 Tumour replaced by granulation tissue and necrosis, no cancer cells
(ATC on initial fine-needle aspiration cytology)  
Yes Cervical esophagus Stage IVB
T4bN0MO
>2 years
3 Kurukahvecioglu et al. [22] 35/F Rapidly growing right thyroid nodule initially Tracheal mass 9 months later Suspicious right neck nodes on PET-CT 5 months later   Right lobectomy Interval radical excision of tracheal mass and left lobectomy
Interval right radical ND
No Adjuvant CTX and RT after 2nd surgery 2.1 × 1.5 Right thyroid nodule: benign Tracheal mass: ATC, 3 LN positive
Right ND: negative
Yes Trachea and strap muscles Stage IVB
T4bN1aM0
>3 years after second surgery
4 Noguchi et al. [28] 51/M Rapidly growing right thyroid nodule with mild tenderness Right lobectomy with right levels 2-4 and level 6 ND with intraoperative RT No Oral valproic acid daily NeoadjuvantCRT Adjuvant CTX 3 × 4.1 × 3.5 Tumour surrounded by fibrous tissue divided by thin ring of PTC; encapsulating fibrous tissue contained remnants of ATC LN: 4 out of 26 positive Yes Strap muscles Stage IVB
T4bN1M0
>2 years
5 Olthof et al. [31] 76/F Enlarging anterior neck mass TT with left modified radical neck dissection (levels 2-6) Yes Adjuvant radioactive iodine therapy I131 Adjuvant RT 7 × 6 × 4 Hürthle cell carcinoma dedifferentiated to ATC with differentiation along rhabdomyoblastic cell lines Level 2 LN positive Yes Regional cervical LN Stage IVB
T4aN1aM0
>3 years
6 Liu et al. [23] 68/M Anterior neck mass with compressive symptoms and dyspnoea   TT with removal of enlarged LNs No Adjuvant RT 5 × 3 × 4 ATC LN negative Yes Strap muscles     Stage IVB
T4bN0M0
>10 years
7 Pichardo-Lowden et al. [26] 26/F Rapidly growing anterior neck mass with odynophagia and voice change   TT and left modified radical ND No Adjuvant CRT 5 × 4 Undifferentiated carcinoma LN negative   Yes Tracheal wall, strap and sternocleidomastoid muscles, encasing left internal jugular vein and adhering to common carotid artery Stage IVB
T4bN0M0
>2 years
8 Akaishi et al. [24] 48/F Not known Now known but completely resected No No <5 Incidental small focus of ATC Yes Not known Stage IVB >12 years 7 months
9 Akaishi et al. [24] 68/F Not kwown Not known but debulking done Not known Adjuvant RT and CTX <5 Incidental small focus of ATC Yes Not known Stage IVB 9 years
10 Akaishi et al. [24] 66/F Not known Not known but completely resected No Adjuvant RT and CTX >5 ATC Yes Not known Stage IVB >3 years
11 Kihara et al. [32] 82 Immobile thyroid mass Subtotal thyroidectomy Not known Adjuvant CRT 4.9 ATC Yes Surrounding muscle Stage IVB
T4bN0M0
6 years 4 months
12 Kim et al. [33] 57/F Not known TT Not known Adjuvant RT and CTX 5 ATC Yes Not known Stage IVB 4 years 4 months
13 Kim et al. [33] 55/F Not known TT Not known Adjuvant RT 4 ATC Yes Not known   Stage IVB >3 years 5 months
14 Siironen et al. [34] 85/F Not known Thyroid lobectomy Not known Adjuvant RT Not known ATC Yes Recurrent laryngeal nerve Stage IVB
T4bN0M0
>6 years 6 months
15 Siironen et al. [34] 62/M Not known Radical surgery including TT Not known Adjuvant CRT Not known ATC Yes Not known Stage IVB
T4bN0M0
5 years 4 months
16 De Crevoisier et al. [29] 75/M Not known Macroscopically complete resection Not known Adjuvant CRT Not known ATC concomitant with PTC or FTC Yes Not known Stage IVB
T4bN1M0
6 years 6 months
17 De Crevoisier et al. [29] 72/F Not known Incomplete resection No Adjuvant CRT  Not known ATC concomitant with PTC or FTC Yes Not known Stage IVB
T4bN0M0
>4 years
18 De Crevoisier et al. [29] 52/F Not known Macroscopically complete resection Not known Neoadjuvant CRT  Not known ATC Yes Regional cervical LN Stage IVB
T4bN1M0
2 years 3 months
19 De Crevoisier et al. [29] 75/F Not known Macroscopically complete resection Not known Adjuvant CRT  Not known ATC Yes Regional cervical LN Stage IVB
T4bN1M0
2 years 1 month
20 De Crevoisier et al. [29] 58/M Not known Incomplete resection No Adjuvant CRT  Not known ATC concomitant with PTC or FTC Yes Regional cervical LN     Stage IVB
T4bN1M0
2 years 1 month
21 Ito et al. [35] 77/F Not known TT and ND Yes Adjuvant CRT Not known ATC Yes Local spread and regional cervical LN Stage IVB
T4bN1M0
>4 years 6 months
22 Rodriguez et al. [36] 58/M Not known Total thyroidectomy and multiple LN dissections (5) Not known Adjuvant CTX Not known ATC with associated PTC Yes Local spread and regional cervical LN Stage IVB
T4bN1M0
>5 years 10 months

Table 1: Cases of locally advanced (T4b) ATC with long-term survival of >2 years.

There have been 3 cases with comparable survival in the literature with survival of more than 9, 10 and 12 years [23,24]. All cases were characterized by having just an incidental focus of ATC within an otherwise well-differentiated thyroid carcinoma with limited extrathyroidal spread. Our case however, was different as our patient presented with a gross ATC tumour with tracheal invasion and we were fortunate that the disease was still surgically resectable.

A widely cited staging system by Shin et al. [30] for papillary thyroid cancer is based on the depth of tracheal invasion. Stage I disease abuts the external perichondrium of the trachea but without cartilaginous erosion. Stage II disease invades into the cartilage or causes cartilage destruction. Stage III disease extends into the lamina propria of the tracheal mucosa. Stage IV disease is full-thickness invasion through the tracheal mucosa. There is no similar staging system for ATC but based on the above, the degree of tracheal invasion for our case would be classified as Stage 3. Based on the histological examination, the tumour was about 2 mm from the closest tracheal resection margin with tumour seen beneath the epithelium of the trachea. The involved tracheal segment was completely resected and primary anastomosis was performed.

Our case represents an anecdotal case wherein it is possible to achieve cure with clear surgical margins. Although there is general reluctance to attempt surgical resection in anaplastic carcinoma due to uniformly poor prognosis, our case concurs with the American Thyroid Guidelines on ATC [14] in which patients with ATC and extra-thyroidal invasion should have en bloc resection if grossly negative margins can be achieved. In our opinion, being able to achieve clear negative margins is the single most important prognostic factor for patients with ATC.

Conclusion

The prognosis of ATC remains poor as it is characterized by aggressive and extensive disease at presentation, the inability in most patients to perform radical enough surgery in order to achieve clear margins, high morbidity of complete extirpation and limited response to radiotherapy or chemotherapy. However, if complete surgical resection is possible, patients should be treated aggressively with a combination of surgery and adjuvant radiotherapy.

References

Citation: Fu WZE, Lim MY, Chuah KL, Chuah KL, Khoo LCM (2015) Locally Advanced Anaplastic Thyroid Carcinoma with Long-Term Survival of More Than 7 Years after Combined Surgery Including Tracheal Resection and Radiotherapy: Case Report. Otolaryngology 5:197. Doi: 10.4172/2161-119X.1000197

Copyright: © 2015 Fu WZE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences

Worldwide Forum on Otolaryngology and ENT Surgery

Barcelona, Spain

6th European Otolaryngology-ENT Surgery Conference

Vienna, Austria
Article Usage
  • Total views: 13126
  • [From(publication date): 7-2015 - Feb 27, 2020]
  • Breakdown by view type
  • HTML page views: 9315
  • PDF downloads: 3811
Share This Article
Top